We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Herceptin

News List

Pfizer and Genentech Duke it Out in Court Over Herceptin Biosimilar Patents biospace
November 23, 2017
Genentech, a Roche company, sued Pfizer in a federal court in Wilmington, Delaware, over Pfizer’s biosimilar for Genentech’s Herceptin.
Biocon pulls EU Herceptin biosim app but expects to return to the race next quarter fiercepharma
August 17, 2017
Biocon says it expects to finish plant fixes required by the European Medicines Agency by the end of August and will resubmit its application for a Herceptin biosimilar after that.
Roche’s Herceptin facing further biosimilar threats in US pharmaphorum
August 03, 2017
Roche’s breast cancer blockbuster Herceptin could face further competition in the US when its patent expires in the coming years...

Previous page 1 2 3 Next page